Analysis on the clinical characteristics and outcomes of patients with chronic myeloid leukemia in chronic phase after discontinuation of tyrosine kinase inhibitor therapy

JIN Ke-yi; ZHANG Lan; WANG Sheng-jie

doi:10.3969/j.issn.1674-3806.2022.09.09

Home>Articles>Analysis on the clinical characteristics and outcomes of patients with chronic myeloid leukemia in chronic phase after discontinuation of tyrosine kinase inhibitor therapy

DOI: 10.3969/j.issn.1674-3806.2022.09.09

Analysis on the clinical characteristics and outcomes of patients with chronic myeloid leukemia in chronic phase after discontinuation of tyrosine kinase inhibitor therapy

JIN Ke-yi

ZHANG Lan

WANG Sheng-jie

Machine-generated Keywords：

Publication Date：2022-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 822-826 )

Chinese Journal of New Clinical Medicine

ISSN：1674-3806

Year, Vol.(Issue)：2022,15(9)